Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2012 1
2013 2
2015 2
2016 2
2017 1
2018 4
2019 2
2020 5
2021 5
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Allogeneic stem cell transplantation in adults 2015-21.
Vo CD, Myhre AE, Abrahamsen IW, Remberger M, Mattsson J, Fløisand Y, Grønvold BCL, Tjønnfjord GE, Tvedt THA, Gedde-Dahl T. Vo CD, et al. Among authors: tjonnfjord ge. Tidsskr Nor Laegeforen. 2023 Mar 13;143(4). doi: 10.4045/tidsskr.22.0521. Print 2023 Mar 14. Tidsskr Nor Laegeforen. 2023. PMID: 36919291 Free article. English, Norwegian.
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial.
Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO. Gudmundstuen AM, et al. Among authors: tjonnfjord ge. Ann Hematol. 2023 Apr;102(4):927-935. doi: 10.1007/s00277-023-05149-x. Epub 2023 Mar 3. Ann Hematol. 2023. PMID: 36864210 Free PMC article. Clinical Trial.
Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.
Diep PP, Rueegg CS, Burman MM, Brinch L, Bø K, Fosså K, Landrø L, Loge JH, Lund MB, Massey RJ, Myrdal OH, Pathak M, Rimstad L, Tanem KE, Tjønnfjord GE, Aaløkken TM, Ruud E. Diep PP, et al. Among authors: tjonnfjord ge. J Adolesc Young Adult Oncol. 2023 Feb;12(1):66-75. doi: 10.1089/jayao.2021.0196. Epub 2022 May 11. J Adolesc Young Adult Oncol. 2023. PMID: 35544321
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes.
Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT, Buechner J, Garcia KC, Schumacher TN, van Veelen PA, Leisegang M, Jacobsen SEW, Woll P, Olweus J. Ali M, et al. Among authors: tjonnfjord ge. Nat Biotechnol. 2022 Apr;40(4):488-498. doi: 10.1038/s41587-021-01089-x. Epub 2021 Dec 6. Nat Biotechnol. 2022. PMID: 34873326 Free PMC article.
Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery.
Tvedt THA, Steien E, Øvrebø B, Haaverstad R, Hobbs W, Wardęcki M, Tjønnfjord GE, Berentsen SA. Tvedt THA, et al. Among authors: tjonnfjord ge. Am J Hematol. 2022 Feb 1;97(2):E51-E54. doi: 10.1002/ajh.26409. Epub 2021 Dec 11. Am J Hematol. 2022. PMID: 34778998 Free article. No abstract available.
30 results